PER

0.00%

8.0¢ percheron therapeutics limited

DMD and MS partnerships for 1102 and another one for...

First 2 Last

Share
Profile

Follow
monti901

964 Posts.

329

05/08/17

16:24

Post #: 26313009
Share

Originally posted by itsagas ↑

DMD.
ANP could be on a winner.Big $ to be made .Bio Marin paid $680 mill for a unproven drug.

BioMarin gambled $680 million in cash when it decided to buy Prosensa and its failed DMD drug drisapersen and make a bid to revive its prospects at the FDA. That effort was hit head on by the FDA’s rejection in early 2016. If BioMarin chooses to go for another exon-skipping drug, the company has rights to opt in on a co-exclusive deal with Sarepta...

ANP have enlisted a Board of international experts in DMD.......So Atl 1102 must have merit in the treatment for DMD.

The clinical trial of ATL1102 is planned to be undertaken at the Royal Children’s Hospital (RCH) in Melbourne, with the clinical development of ATL1102 in boys with DMD to be directed by an Advisory Board of international experts in the field. The Advisory Board is chaired by Mr William Goolsbee, a non-executive director of ANP and ex-Chairman of Sarepta Therapeutics (Sarepta are marketers of the antisense drug, eteplirsen, the first and only drug approved for the restoration of muscle dystrophin). Membership of the Advisory Board includes the Australian inventors of eteplirsen, Professor Steve Wilton and Professor Sue Fletcher (from Perth’s Western Australian Neuroscience Research Institute and Murdoch University respectively), and Dr Gillian Butler-Browne, Director, Centre of Research in Myology at Sorbonne University in Paris (whose team observed that circulating high CD49d expressing T- cells lead to poor prognosis in DMD patients).

Expand

DMD and MS partnerships for 1102 and another one for Acromegaly/1103 would obviously put ANP right up there as a takeover target for big pharma. Goolsbee has been bought on board to fastrack these agreements, he clearly has the credentials and contacts to make this happen. Eagerly awaiting a positive outcome... good luck to all holders...

ANP Price at posting: 3.7¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

MCT

Metalicity looking for offers on Admiral Bay zinc project

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

There are more pages in this discussion • 73 more messages in this thread...

First 2 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
7.9¢	8.0¢	7.9¢	$12.63K	158.7K

Buyers (Bids)

No.	Vol.	Price($)
2	66500	7.6¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	273231	2

View Market Depth

No.	Vol.	Price($)
2	66500	0.076
4	206988	0.075
2	353708	0.074
1	100000	0.072
2	310000	0.071

Price($)	Vol.	No.
0.080	273231	2
0.082	255785	2
0.083	110520	2
0.084	157142	2
0.085	553000	3

Last trade - 15.26pm 19/07/2024 (20 minute delay)

PER (ASX) Chart

DMD and MS partnerships for 1102 and another one for...

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Metalicity looking for offers on Admiral Bay zinc project

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

DMD and MS partnerships for 1102 and another one for...

Top Stories

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Metalicity looking for offers on Admiral Bay zinc project

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News